Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FAKKH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,399
Award facts
- Contract value 100% obligated
- $22,398.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22,398.81 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300 mg pen injectors (2 mL), with an ultimate completion date of January 9, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026). AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and federal healthcare systems, delivering this immunosuppressant medication to support medical supply chain requirements across the defense healthcare enterprise.
This delivery order exemplifies the types of specialty pharmaceutical products procured through DLA's pharmaceutical prime vendor contracts, which furnish branded and generic medications, vaccines, and medical supplies to military treatment facilities and veteran healthcare programs globally. AmerisourceBergen's parent company, Cencora, Inc. (also known as AmerisourceBergen), holds the overarching indefinite delivery vehicle with DLA, enabling efficient fulfillment of recurring medical commodity requirements across multiple therapeutic domains. The contract's firm fixed-price structure and competitive award status reflect the company's demonstrated capability to meet federal procurement standards for essential pharmaceutical products supporting military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FAKKH?
SPE2DR26FAKKH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FAKKH worth?
The government has obligated $22,399 on SPE2DR26FAKKH.
Is contract SPE2DR26FAKKH an order under another contract?
Yes. SPE2DR26FAKKH is a delivery order under SPE2DR25D1201, an indefinite delivery contract.
Was contract SPE2DR26FAKKH competed?
The extent of competition for SPE2DR26FAKKH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award